(Q52026922)
Statements
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. (English)
1 reference
D S Knopman
1 reference
M J Knapp
1 reference
P R Solomon
1 reference
W W Pendlebury
1 reference
C S Davis
1 reference
S I Gracon
1 reference
1 April 1994
1 reference
271
1 reference
13
1 reference
985-991
1 reference